Selenium and vitamin E: Interesting biology and dashed hope

Journal of the National Cancer Institute

Volumn 101, Issue 5, 2009, Pages 283-285

  Klein, Eric A ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; FINASTERIDE; LYCOPENE; PLACEBO; SELENIUM; SELENOMETHIONINE;

ADJUVANT THERAPY; BIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL TRIAL; DIET RESTRICTION; EDITORIAL; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; OVERALL SURVIVAL; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENOMETHIONINE; TREATMENT FAILURE;

EID: 62349103671     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp009     Document Type: Editorial

References (14)

1. Clark LC, Combs GF Jr, Turnbull BW, et al. Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA. 1996;276(24):1957-1963.
2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-1035.
3. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85(18):1483-1492.
4. Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial. J Urol. 2001;166(4):1311-1315.
5. Tsavachidou D, McDonnell TJ, Wen S, et al. Selenium vitamin E: cell type-and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009;101(5):306-320.
6. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51.
7. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II Randomized Controlled Trial. JAMA. 2009;301(1):52-62.
8. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II Randomized Controlled Trial. JAMA. 2008;300(18):2123-2133.
9. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97(2):94-102.
10. Mikhak B, Hunter DJ, Spiegelman D, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis. 2008;29(12):2335-2340.
11. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224.
12. Gann PH. Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance-next, cause. JAMA. 2009;301(1):102-103.
13. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea(NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst. 2003;95(21):1578-1586.
14. Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008;105(24):8369-8374.